{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:37:20Z","timestamp":1767962240621,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2843,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Norwegian Research Council, the Norwegian Cancer Society, the EU sixth framework, and Helse Midt-Norge RHF"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jpainsymman.2011.05.008","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T06:16:10Z","timestamp":1327990570000},"page":"694-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Is Oxycodone Efficacy Reflected in Serum Concentrations? A Multicenter, Cross-Sectional Study in 456 Adult Cancer Patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Trine Naalsund","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Klepstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Bjordal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2011.05.008_bib1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpain.2009.05.006","article-title":"Increasing use of opioids from 2004 to 2007-Pharmacoepidemiological data from a complete national prescription database in Norway","volume":"14","author":"Fredheim","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1185\/030079908X253708","article-title":"Oxycodone: a review of its use in the management of pain","volume":"24","author":"Riley","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/11539950-000000000-00000","article-title":"Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study","volume":"31","author":"Gronlund","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00228-010-0948-5","article-title":"Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients","volume":"67","author":"Andreassen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/ane.0b013e3181605a15","article-title":"Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia","volume":"106","author":"Lemberg","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9236(98)90051-0","article-title":"Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"64","author":"Heiskanen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.2010.00709.x","article-title":"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/0024-3205(94)00849-3","article-title":"The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats","volume":"54","author":"Leow","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1742-7843.2009.00378.x","article-title":"The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism","volume":"104","author":"Zwisler","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib12","series-title":"Oxford textbook of palliative medicine","first-page":"661","article-title":"Opioid analgesic therapy","author":"Fallon","year":"2010"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In\u00a0vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostrom","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2006.01.010","article-title":"Current evidence for a genetic modulation of the response to analgesics","volume":"121","author":"Lotsch","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","article-title":"The influence from genetic variability on opioid use for cancer pain. An European study of 2294 cancer pain patients","volume":"152","author":"Klepstad","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib18","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","article-title":"When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function","volume":"61","author":"Serlin","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0885-3924(95)00052-Z","article-title":"A\u00a0prospective multicenter assessment of the Edmonton staging system for cancer pain","volume":"10","author":"Bruera","year":"1995","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib22","series-title":"The EORTC QLQ C-30 scoring manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#","article-title":"The frequency and clinical course of cognitive impairment in patients with terminal cancer","volume":"79","author":"Pereira","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(09)70018-X","article-title":"Palliating delirium in patients with cancer","volume":"10","author":"Caraceni","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","article-title":"The Mini-Mental State Examination: a comprehensive review","volume":"40","author":"Tombaugh","year":"1992","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0033291700046730","article-title":"Limits of the \u201cMini-Mental State\u201d as a screening test for dementia and delirium among hospital patients","volume":"12","author":"Anthony","year":"1982","journal-title":"Psychol Med"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","article-title":"Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients","volume":"17","author":"Klepstad","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Statist Soc B"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do a regression analysis","volume":"26","author":"Green","year":"1991","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib32","series-title":"Applying regression & correlation: A guide for students and researchers","author":"Miles","year":"2001"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","article-title":"Morphine and oxycodone hydrochloride in the management of cancer pain","volume":"47","author":"Kalso","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib34","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","article-title":"Opioids in pain management","volume":"353","author":"McQuay","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib36","first-page":"447","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0885-3924(99)00079-2","article-title":"Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?","volume":"18","author":"Salzman","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpainsymman.2009.07.010","article-title":"A\u00a0systematic review of oxymorphone in the management of chronic pain","volume":"39","author":"Mayyas","year":"2010","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2147\/TCRM.S1784","article-title":"Review of oral oxymorphone in the management of pain","volume":"4","author":"Sloan","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2010.00673.x","article-title":"The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00228-010-0893-3","article-title":"Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"67","author":"Kummer","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/J354v21n04_14","article-title":"Role of corticosteroids in palliative care","volume":"21","author":"Shih","year":"2007","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/02841860500401167","article-title":"The use of corticosteroids in Swedish palliative care","volume":"45","author":"Lundstrom","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","article-title":"Opioid induced hyperalgesia: clinical implications for the pain practitioner","volume":"12","author":"Silverman","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2011.05.008_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1526-4637.2009.00653.x","article-title":"Do opioids induce hyperalgesia in humans? An evidence-based structured review","volume":"10","author":"Fishbain","year":"2009","journal-title":"Pain Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411005148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411005148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:07:25Z","timestamp":1760130445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392411005148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0885392411005148"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.05.008","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Oxycodone Efficacy Reflected in Serum Concentrations? A Multicenter, Cross-Sectional Study in 456 Adult Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}